Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
HK Stock MarketDetailed Quotes
7ROAD (00797)
- 0.620
- 0.0000.00%
Trading Jan 16 09:00 CST
1.71BMarket Cap-41.33P/E (TTM)
0.000High0.000Low0Volume0.000Open0.620Prev Close0.00Turnover0.00%Turnover RatioLossP/E (Static)2.75BShares1.60052wk High0.91P/B1.71BFloat Cap0.25552wk Low--Dividend TTM2.75BShs Float3.340Historical High--Dividend LFY0.00%Range %0.255Historical Low--Avg Price2000Lot Size--Div Yield TTM--Div Yield LFY
7ROAD (00797) Income Statement
All
YOY
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 26.54%176.39M | -36.82%306.4M | -62.02%139.39M | -10.30%484.95M | 79.46%366.96M | 28.56%540.63M | 86.68%204.48M | -0.89%420.54M | -44.77%109.53M | 27.28%424.31M |
| Operating income | 26.54%176.39M | -36.82%306.4M | -62.02%139.39M | -10.30%484.95M | 79.46%366.96M | 28.56%540.63M | 86.68%204.48M | -0.89%420.54M | -44.77%109.53M | 27.28%424.31M |
| Cost of sales | -49.90%-53.75M | -11.11%-94.11M | 12.55%-35.86M | 69.69%-84.7M | 71.52%-41M | -42.51%-279.43M | -130.47%-143.98M | -76.90%-196.07M | -43.02%-62.47M | -175.38%-110.84M |
| Operating expenses | -49.90%-53.75M | -11.11%-94.11M | 12.55%-35.86M | 69.69%-84.7M | 71.52%-41M | -42.51%-279.43M | -130.47%-143.98M | -76.90%-196.07M | -43.02%-62.47M | -175.38%-110.84M |
| Gross profit | 18.45%122.64M | -46.96%212.29M | -68.24%103.53M | 53.23%400.25M | 438.76%325.96M | 16.36%261.2M | 28.56%60.5M | -28.39%224.47M | -69.57%47.06M | 6.94%313.48M |
| Selling expenses | 35.07%-24.69M | -27.62%-63.6M | -54.36%-38.02M | 56.87%-49.84M | -103.36%-24.63M | -782.70%-115.56M | -73.12%-12.11M | 54.63%-13.09M | 55.97%-7M | -37.44%-28.86M |
| Administrative expenses | -39.81%-29.81M | 22.80%-45.97M | 27.25%-21.32M | 1.66%-59.55M | -12.25%-29.31M | 18.81%-60.55M | 23.67%-26.11M | -3.05%-74.58M | 8.54%-34.21M | -23.23%-72.37M |
| Research and development expenses | 53.21%-33.07M | 21.69%-131.87M | 27.85%-70.69M | -30.05%-168.4M | -118.80%-97.98M | -62.01%-129.48M | -27.35%-44.78M | 25.70%-79.92M | 48.18%-35.16M | 4.30%-107.57M |
| Impairment and provision | 74.86%-3.73M | 23.79%-25.47M | -75.72%-14.84M | -192.00%-33.42M | -28.08%-8.45M | -355.78%-11.45M | -604.20%-6.6M | -22.72%4.48M | -90.80%1.31M | 115.81%5.79M |
| -Other impairment is provision | 74.86%-3.73M | 23.79%-25.47M | -75.72%-14.84M | -192.00%-33.42M | -28.08%-8.45M | -355.78%-11.45M | -604.20%-6.6M | -22.72%4.48M | -90.80%1.31M | 115.81%5.79M |
| Special items of operating profit | -97.03%1.09M | 92.73%-5.81M | 419.99%36.56M | -121.99%-79.86M | -103.41%-11.42M | 1,637.29%363.22M | 2,485.07%335.13M | 54.81%-23.63M | 148.98%12.96M | 6.91%-52.29M |
| Operating profit | 776.95%32.42M | -757.77%-60.43M | -103.11%-4.79M | -97.01%9.19M | -49.62%154.17M | 714.80%307.37M | 2,135.47%306.03M | -35.16%37.72M | -170.74%-15.04M | 609.50%58.18M |
| Financing income | 306.57%805K | -46.54%595K | -69.91%198K | 73.36%1.11M | 113.64%658K | -61.92%642K | -58.66%308K | 109.70%1.69M | 61.26%745K | -1.11%804K |
| Financing cost | -31.35%-1.5M | -3.32%-1.87M | -28.60%-1.14M | 91.33%-1.81M | 83.07%-888K | -564.33%-20.82M | -176.40%-5.25M | 18.98%-3.13M | -6.75%-1.9M | -24.77%-3.87M |
| Share of profits of associates | 87.69%-145K | -183.84%-1.67M | -497.97%-1.18M | 84.55%-588K | 86.23%-197K | -106.94%-3.81M | -103.84%-1.43M | --54.85M | --37.24M | ---- |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -310.20%-3.22M |
| Earning before tax | 556.94%31.58M | -901.53%-63.37M | -104.50%-6.91M | -97.21%7.91M | -48.70%153.74M | 210.97%283.39M | 1,323.65%299.66M | 75.59%91.13M | 15.93%21.05M | 911.87%51.9M |
| Tax | -1,535.82%-5.48M | -157.46%-12.06M | 87.56%-335K | -23.84%-4.69M | 95.47%-2.69M | -155.15%-3.78M | -732.86%-59.36M | -75.59%6.86M | -34.72%9.38M | 220.21%28.1M |
| After-tax profit from continuing operations | 460.18%26.1M | -2,441.85%-75.43M | -104.80%-7.25M | -98.85%3.22M | -37.14%151.05M | 185.34%279.61M | 689.71%240.3M | 22.49%97.99M | -6.45%30.43M | 475.34%80M |
| After-tax profit from non-continuing business | ---- | 100.86%1.28M | 106.19%1.28M | ---148.12M | ---20.6M | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 537.10%26.1M | 48.82%-74.16M | -104.58%-5.97M | -151.82%-144.89M | -45.72%130.45M | 185.34%279.61M | 689.71%240.3M | 22.49%97.99M | -6.45%30.43M | 475.34%80M |
| Minority shareholders should account for profits from continuing business | -155.89%-1.03M | -144.86%-703K | 2,892.42%1.84M | --1.57M | ---66K | ---- | ---- | ---- | ---- | ---- |
| Minority profit | -155.89%-1.03M | -144.86%-703K | 2,892.42%1.84M | 154.17%1.57M | 33.33%-66K | -177.06%-2.89M | -39.44%-99K | 387.00%3.75M | -148.30%-71K | -142.00%-1.31M |
| Shareholders should account for profits from continuing business | 398.48%27.13M | -4,618.02%-74.73M | -106.01%-9.09M | --1.65M | --151.12M | ---- | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | 100.86%1.28M | 106.19%1.28M | ---148.12M | ---20.6M | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 447.18%27.13M | 49.85%-73.45M | -105.99%-7.81M | -151.84%-146.46M | -45.71%130.51M | 199.78%282.5M | 688.20%240.4M | 15.90%94.24M | -5.80%30.5M | 653.49%81.31M |
| Basic earnings per share | 466.67%0.011 | 49.91%-0.0285 | -105.88%-0.003 | -151.87%-0.0569 | -45.16%0.051 | 199.73%0.1097 | 675.00%0.093 | 9.91%0.0366 | -7.69%0.012 | 656.82%0.0333 |
| Diluted earnings per share | 466.67%0.011 | 49.91%-0.0285 | -105.88%-0.003 | -151.87%-0.0569 | -45.16%0.051 | 199.73%0.1097 | 675.00%0.093 | 9.91%0.0366 | -7.69%0.012 | 656.82%0.0333 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unaudited opinion |
| Auditor | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
New Consumption Stocks New Consumption Stocks
New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations. New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations.
View More
Hot Topics Hot Topics
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde
年頭旺到年尾
Aug 21, 2025 06:11
Are you foolish? What's the point of knowing your mistakes?
牛牛課堂
Sep 12, 2025 17:29
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?